Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination
Sign Up to like & getrecommendations! Published in 2024 at "Nature Immunology"
DOI: 10.1038/s41590-024-01787-z
Abstract: Vaccines have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) morbidity and mortality, yet emerging variants challenge their effectiveness. The prevailing approach to updating vaccines targets the antibody response, operating under the presumption that it… read more here.
Keywords: sars cov; conferred prior; prior infection; antibody ... See more keywords